Latest News
Exact Sciences gains FDA approval for Cologuard Plus Test
4 October 2024 - Molecular diagnostics company Exact Sciences Corp. (NASDAQ:EXAS) announced on Friday that it has received FDA approval for its next-generation multitarget stool DNA test, Cologuard Plus.This test is approved for adults aged 45 and ol...
Amyris enters agreement with BioMaP-C
4 October 2024 - Biotechnology company Amyris announced on Thursday that it has been awarded an agreement through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-C) for USD12.3m from the Administration for Strategic Preparedness a...
ABL Bio signs clinical trial collaboration and supply agreement with MSD
4 October 2024 - Biotech company ABL Bio announced on Friday that it has signed a clinical trial collaboration and supply agreement with MSD, a subsidiary of US-based Merck & Co., Inc.Under the agreement, the companies are to assess ABL103 in com...
Avidity Biosciences reports partial clinical hold on delpacibart etedesiran lifted
3 October 2024 - Biopharmaceutical company Avidity Biosciences Inc (Nasdaq: RNA) said on Thursday that the US Food and Drug Administration (FDA) has removed the partial clinical hold on delpacibart etedesiran (del-desiran/AOC 1001).This investigation...
Ferring expands gene therapy manufacturing capabilities
3 October 2024 - Privately owned specialty biopharmaceutical group Ferring Pharmaceuticals announced on Thursday that it has opened a new manufacturing facility in Finland for the drug substance of its intravesical non-replicating gene therapy Adstil...